Shanghai NK Cell Tech Co., Ltd.

Chine

Commandez votre montre hebdomadaire Shanghai NK Cell Tech Co., Ltd.
Quantité totale PI 20
Rang # Quantité totale PI 76 300
Note d'activité PI 2,5/5.0    35
Rang # Activité PI 21 571

Brevets

Marques

4 0
0 0
16 0
0
 
Dernier brevet 2025 - Synnotch receptor and use thereof
Premier brevet 2022 - Bispecific nk cell agonist, prep...

Derniers inventions, produits et services

2025 Invention Synnotch receptor and use thereof. The present disclosure provides a chimeric polypeptide. The c...
Invention Method for in-vitro induction amplification of nk cells with high purity and high cytotoxic activ...
2024 Invention Use of chimeric antigen receptor targeting non-classical hla molecules for cancer therapy. Provid...
Invention Use of chimeric antigen receptor specifically targeting non-classical tumor hla molecule. Provide...
Invention Chimeric antigen receptor cell specifically targeting tumor, preparation method therefor and use ...
Invention Chimeric antigen receptor and use thereof. Provided are a chimeric antigen receptor and the use t...
Invention Chimeric switch receptor and use thereof. Provided are a chimeric switch receptor (CSR) capable o...
Invention Bispecific nk cell agonist, preparation method, and application. The present disclosure relates ...
Invention Bispecific antibodies and use thereof. Provided are a bispecific antibody and a use thereof. The...
2023 Invention Synnotch receptor and use thereof. Provided in the present invention is a chimeric polypeptide. T...
Invention Preparation and use of car-nk cell with enhanced capacity to infiltrate tumor sites. The present ...
Invention Method for preparing nk cells capable of reversing inhibitory signal from tumor microenvironment ...
Invention Transgenic immune cell and use thereof. The present invention provides a transgenic immune cell a...
Invention Car-immune cell for knocking down nkg2a gene and use thereof. The present invention provides a CA...
Invention Method for preparing nk cells for silencing nkg2a gene and use thereof. Provided are a sgRNA mole...
Invention Method for improving viability and anti-tumor activity of nk cells and use thereof. The present i...
Invention Preparation method for and use of chimeric switch receptor gene modified nk cell. The present inv...
2022 Invention Bispecific antibody and use thereof. A bispecific antibody and a use thereof. The bispecific anti...
Invention Bispecific nk cell agonist, preparation method, and application. The present disclosure relates t...